Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Computer-Aided Image Diagnostic Designed for Enhanced Breast Tumor Diagnosis

By HospiMedica International staff writers
Posted on 13 Nov 2013
Researchers are developing computer-aided diagnosis (CADx) and quantitative image analysis (QIA) techniques for mammograms, ultrasound images, and magnetic resonance image (MRI) scans to identify specific tumor characteristics, including shape, size, and sharpness.

The lead researcher of the study, Maryellen Giger, is a professor of radiology/medical physics and director of the Imaging Research Institute at the University of Chicago (IL, USA). More...
Currently, computer-aided detection provides a “second opinion” to a radiologist in identifying suspicious areas within mammograms. Next, radiologists will ultimately be able to use computer-extracted lesion characteristics when performing a diagnosis to assess whether the tumor is cancerous.

The role of quantitative image analysis is expanding beyond screening and toward application of risk assessment, diagnosis, prognosis, and response to therapy, and in using data to identify how tumor characteristics apply to disease states, according to Prof. Giger. This could lead to the comparison of a tumor’s features with thousands of similar cases, enabling the exploration of complex relationships among tumor characteristics across large populations, which may ultimately contribute to the design of patient-specific treatments. It could also be used to study the association between a tumor’s observable characteristics and cell-level data for the emerging field of imaging and genomics, with a goal of identifying genes that influence the risk for disease.

Whereas these findings are exciting for digital mammogram technology, researchers are expanding their analysis to breast ultrasound and MRI scans due to the need for clinical validation within a larger screening population.

Through research between genomics and image-based characteristics, the researchers could soon be able to clarify which tumor characteristics are related to and which complement genetic findings, with the ultimate goal of merging them to include both genetic and environmental factors in clinical decisions. Researchers are now using data-mining methods to identify those possible correlations.

The study’s findings were published October 14, 2013, in the SPIE Newsroom.

Related Links:

University of Chicago



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Hybrid Arch Device
Neo EDE
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Sphere-9 is the first all-in-one mapping and ablation, large-tip focal, dual-energy catheter to be CE marked for ventricular ablation (Photo courtesy of Medtronic)

Dual-Energy Mapping and Ablation Catheter Receives CE Mark for Ventricular Arrhythmias

Ventricular arrhythmias, including ventricular tachycardia and premature ventricular complexes, can be life-threatening and often occur in patients with advanced heart disease. Although catheter ablation... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.